Gut microbes implicated in bladder cancer
Study shows that gut bacteria can metabolise carcinogens and cause them to accumulate in distant organs, leading to tumour development.
SCIENCE & TECHNOLOGY2024
science-technology
Common medications accumulate in gut bacteria
A new collaborative study led by EMBL group leaders Kiran Patil, Nassos Typas, and Peer Bork has found that common medications accumulate in human gut bacteria. This process reduces drug effectiveness and affects the metabolism of common gut microbes, thereby altering the gut microbiome.
SCIENCE & TECHNOLOGY2021
sciencescience-technology
Michael Zimmermann receives FEBS Anniversary Prize
The Gesellschaft für Biochemie und Molekularbiologie has awarded a FEBS Anniversary Prize to Michael Zimmermann for his gut microbiome research.
EMBL ANNOUNCEMENTSLAB MATTERS2021
embl-announcementslab-matters
No results found